EDAP to showcase Ablatherm-HIFU technology and Sonolith i-sys lithotripter at AUA 2010 Annual Meeting

EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced it will have a strong presence in both the exhibition and the scientific program at the American Urological Association (AUA) 2010 Annual Meeting, being held May 29 – June 3, 2010 in San Francisco. EDAP will showcase its Ablatherm-HIFU technology and Sonolith i-sys lithotripter at its exhibition booth # 1938 of the Moscone Convention Center.

Marc Oczachowski, EDAP's Chief Executive Officer, commented, "We look forward to showcasing our minimally invasive technologies to the global urology audience. We will take this opportunity to present four abstracts that outline our long-term positive European experience utilizing our HIFU treatment of localized prostate cancer. Our team of experts from France, Germany and the US will highlight positive Ablatherm-HIFU results obtained with patients who underwent HIFU as primary care or as a salvage treatment after radiotherapy failure or hormone-therapy failure. Our strong European patient database registry is proving to be a supportive tool to compile these positive results and assist in validating Ablatherm-HIFU's effectiveness. Two separate abstracts addressing our lithotripsy technology for urinary stones will also be presented at the AUA."

Mr. Oczachowski, continued, "I am very pleased to invite and welcome all urologists, partners and investors to visit EDAP's team at our booth to discuss our technologies and strategies further."